American Century Companies Inc. Acquires 39,185 Shares of HealthEquity, Inc. (NASDAQ:HQY)

American Century Companies Inc. lifted its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 7.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 570,952 shares of the company’s stock after acquiring an additional 39,185 shares during the period. American Century Companies Inc.’s holdings in HealthEquity were worth $54,783,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in HQY. 1620 Investment Advisors Inc. lifted its position in HealthEquity by 44.4% in the fourth quarter. 1620 Investment Advisors Inc. now owns 1,973 shares of the company’s stock worth $189,000 after buying an additional 607 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in shares of HealthEquity by 0.6% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,286 shares of the company’s stock valued at $1,850,000 after acquiring an additional 106 shares during the period. Teacher Retirement System of Texas lifted its holdings in shares of HealthEquity by 11.0% in the 4th quarter. Teacher Retirement System of Texas now owns 19,039 shares of the company’s stock worth $1,827,000 after acquiring an additional 1,880 shares during the last quarter. Harvest Fund Management Co. Ltd purchased a new position in shares of HealthEquity during the 4th quarter worth about $512,000. Finally, Xponance Inc. grew its holdings in HealthEquity by 6.2% during the 4th quarter. Xponance Inc. now owns 12,276 shares of the company’s stock valued at $1,178,000 after purchasing an additional 718 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

NASDAQ HQY opened at $89.22 on Thursday. The company has a market cap of $7.72 billion, a PE ratio of 81.85, a P/E/G ratio of 1.60 and a beta of 0.62. The firm’s 50 day moving average price is $104.17 and its 200-day moving average price is $95.89. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 2.20% of the company’s stock.

Wall Street Analyst Weigh In

HQY has been the subject of several analyst reports. Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their price objective for the stock from $120.00 to $115.00 in a research note on Tuesday. JMP Securities boosted their price objective on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. Royal Bank of Canada lifted their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. Mizuho assumed coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target on the stock. Finally, Barrington Research reiterated an “outperform” rating and set a $112.00 price objective on shares of HealthEquity in a report on Friday, March 14th. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $113.31.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.